Inotiv (NOTV) 8-K Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021

Exhibit 23.1

 

Consent of Independent Accounting Firm

To the Directors of Inotiv, Inc.

We consent to the incorporation by reference in the Registration Statement (No. 333-253309) on Form S-3 and in the Registration Statements (Nos. 333-153734, 333-228747 and 333-237580) on Form S-8 of Inotiv, Inc. of our report dated March 24, 2021 (April 6, 2021 with respect to Note 13), relating to the financial statements of Bolder BioPATH, Inc., appearing in the Form 8-K of Inotiv, Inc. to which this consent is included as an exhibit.

We also consent to the reference to our firm under the heading "Experts" in the prospectus which is part of such Registration Statement on Form S-3. 

We have not audited or reviewed any financial statement of Bolder BioPATH, Inc. for any period subsequent to December 31, 2020. Therefore, we are unable to and do not express any opinion or assurance on the financial position, results of operations, or cash flows subsequent to December 31, 2020.

/s/ Soukup Bush & Associates, CPAs, P.C.

Fort Collins, Colorado

April 20, 2021